Tenderwize
Back to tender search

Open house drug discount agreements Nintedanib

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Mar 03, 2028 · 564 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Nintedanib, ATC L01EX09

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

No estimated contract value or maximum framework value is provided. This makes it impossible to assess the financial op...

Paper submissions require two signed originals sent by mail, and electronic submissions require a qualified electronic...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Apr 2028
  • Non-exclusive discount agreements for Nintedanib (ATC L01EX09) with pharmaceutical companies in Bavaria.
  • Open-house model: any eligible pharmaceutical company can join without selection.
Show full summary

Open-house model for non-exclusive drug discount agreements for Nintedanib (ATC L01EX09) by AOK Bayern. Not subject to procurement law. Contracts are offered to all interested pharmaceutical companies that meet eligibility criteria. No selection or award criteria. Contracts run from May 2026 to April 2028, with possible early termination. No estimated value provided.

Risks

No estimated contract value or maximum framework value is provided. This makes it impossible to assess the financial op...

Paper submissions require two signed originals sent by mail, and electronic submissions require a qualified electronic...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Eligibility: only pharmaceutical companies; submit signed self-declaration of reliability.

Administrative

  • Submission: either signed paper copy (two originals) or electronically with qualified electronic signature via DTVP portal.
  • Documents: completed and signed contract, annex listing medicines, and self-declaration of reliability.

Requirements may be incomplete.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house drug discount agreements Nintedanib

Non-exclusive discount agreements for the active substance Nintedanib (ATC L01EX09) under §130a(8) SGB V. All eligible pharmaceutical companies can join. Identical, non-negotiable terms. Contracts run from 01.05.2026 to 30.04.2028. Early termination possible with one month notice. Automatic suspension if a competitive discount contract is concluded.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Apr 2026 - Apr 2028

Category

Pharmaceutical products

Deadline

Deadline Mar 03, 2028

Procurement Details

Publication date
15 Mar 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
181186-2026

Documents (2)

Similar tenders